Aprazer Healthcare – A Trusted Exporter to Key Pharma Markets

Indian pharmaceutical exports serve as a lifeline, enabling access to essential healthcare.

The Quick facts-

• India ranks as the 3rd largest pharmaceutical drug manufacturer.
• Accounts for 20 % of global generic exports.
• India supplies 70 % of the world’s antiretrovirals.
• India forms the backbone of GLOBAL immunization, supplying 60 % of the total vaccines to UNICEF /WHO.

At Aprazer Healthcare (leading pharmaceutical manufacturer in India), we manufacture a global range of lifesaving medicines.

As a leading drug exporter from India, we are trusted for world–class quality and stringent regulatory compliance.

Implementing cutting–edge technology, we specialize in manufacturing complex formulations.

Our export portfolio includes –

• Anticancer drugs
• Hepatitis B medicines
• Hepatitis C medicines
• HIV medicines

Key markets for Pharma exports –

• North America – 

It is a global hub for pharmaceutical trade.

Driven by heavy domestic demand, it relies heavily on foreign generic imports.

Pharmaceutical exports to North American countries exceed $123 billion.

India accounts for roughly 13 to $ 15 billion in drug exports.

It is the top supplier of affordable generic drugs.

The key imports include –

• finished dosage formulations
• complex generics
• biosimilars
• Europe union and UK

These are highly regulated markets.

They demand exceptional quality assurance.

Key imports include API and generic drugs.

India supplies 33% of total generic prescriptions in the UK.

Europe’s pharma market is expected to reach €400 billion by 2027.

Germany, the UK, and the Netherlands are the leading entry ports for continental distribution.

• Latin America (Brazil, Mexico) 

It is a rapidly expanding market.

Brazil and Mexico are the leading importers of bioequivalent generics.

South and Central America heavily rely on generic imports for –

API, Bulk drugs, diabetes, and cardiovascular drugs.

• Africa (South Africa, Kenya, Nigeria)

The African market is projected to grow between $34 billion and $70+ billion over the next decade.

Africa is a high-volume pharmaceutical market.

It deeply relies on imported products.

The key medicines of export include –

Antimalarials, antibiotics, vaccines, and anti-retrovirals.

It is the target of healthcare programs by UNICEF and WHO.

• The Middle East – 

These are the Gulf nations that demand premium formulations.

The global drug export in the Middle East is expected to reach $50 billion by 2026.

The key import products include –

OTC drugs, branded generics, and specialty care medicines.

Due to simplified regulatory pathways, it is the destination for branded product lines.

• South East Asia – 

These countries rely on Indian pharmaceutical imports.

India serves as the best cost-effective drug source in comparison to Western markets.

Vietnam, the Philippines, Myanmar, and Indonesia are the top destinations for export.

ASEAN regulatory framework accepts WHO-GMP baseline compliance.

• CIS and Russia –

Russia accounts for major Pharma imports from India, scaling to $55.7 million in immunological treatments.

The unified single dossier framework eases Indian drug approvals.

The international ICH-compliant trials done in India are now recognized and accepted by the CIS countries.

It streamlines access to other markets –

Belarus, Kazakhstan, Kyrgyzstan, and Armenia.

The key Medicines Exported from India 

Oncology drugs –

India supplies 60 percent of global generic anticancer drugs.

India supplies anti-cancer drugs to 120 + countries.

The key exports include –

Tyrosine kinase inhibitors and chemotherapy injections.

Antiinfectives (Antibiotics and antimalarials)- 

This is the largest volume segment.

The key drugs include-

cephalosporins, penicillins, and macrolides.

18-20 percent of global antibiotic volume is exported by India

Neurological medicine /pain killers –

The massive worldwide demand for OTC painkillers drives high export volumes.

The key drugs of export include the NSAIDs, antidepressants, and the anticonvulsants.

Cardiovascular drugs – 

Indian exports cover 12 -14 % of the global cardiovascular drug market.

The drug exports include – statins, ACE-inhibitors, beta-blockers , calcium channel blocker.

Antivirals and antiretrovirals – India is the leading exporter of HIV drugs in high disease burden areas.

Antidiabetic drugs – The chronic illness projecting a global crisis.

The export volume is dominated by metformin and oral hypoglycemic.

GIT medicines – 

India manufactures and exports a wide variety of GIT medicines.

The key exports include – proton pump inhibitors, H2 blockers and antacids.

Why is Aprazer Healthcare a trusted drug exporter?

• Regulatory compliance
• Assured quality
• Robust Supply chain
• Global distribution
• Wide product portfolio
• Transparent communication